You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nPC

Showing 1 - 25 of 551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reveals Relationship Between gp42-IgG Epitopes and

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Epitope exploration
  • (no location specified)
Jul 16, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Dalpiciclib Isetionate Tablets, Camrelizumab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2023

Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

Recruiting
  • Tuberous Sclerosis Complex
  • NPC-12Y gel
  • NPC-12Y placebo gel
  • Toyoake, Aichi, Japan
  • +4 more
Aug 8, 2022

Safety and Pharmacokinetics Trial in Shinjuku-Ku (NPC-22, NPC-22 Placebo)

Completed
  • Safety and Pharmacokinetics
  • Shinjuku-Ku, Tokyo, Japan
    Medical Corporation Shinanokai Shinanozaka Clinic
Feb 4, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

Nasopharyngeal Carcinoma Trial in Zhongshan (Anrotinib plus Tirelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anrotinib plus Tirelizumab
  • Zhongshan, Guangdong, China
    Zhongshan City People's Hospital
Jul 31, 2023

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

Amyotrophic Lateral Sclerosis Trial in Los Angeles (CNS10-NPC-GDNF)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • CNS10-NPC-GDNF
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anti-EGFR and PD-1 inhibitor arm
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Nasopharyngeal Carcinoma Trial in Xi'an (gemcitabine,nimotuzumab, toripalimab, gemcitabine, cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • gemcitabine,nimotuzumab, toripalimab
  • gemcitabine, cisplatin
  • Xi'an, Shaanxi, China
    Department of Radiation Oncology, Xijing Hospital, Fourth Milita
Sep 5, 2023

Anxiety Disorder, Depressive Disorder Trial in Box Elder (Culturally Adapted Compass for Courage)

Recruiting
  • Anxiety Disorder
  • Depressive Disorder
  • Culturally Adapted Compass for Courage
  • Bozeman, Montana
    Montana State University
Oct 25, 2022

Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
  • (no location specified)
Sep 23, 2023

Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)

Recruiting
  • Advanced Nasopharyngeal Carcinoma
  • SBRT
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Dec 5, 2022

Retinitis Pigmentosa Trial in Beverly Hills (CNS10-NPC implantation)

Recruiting
  • Retinitis Pigmentosa
  • CNS10-NPC implantation
  • Beverly Hills, California
    Retina-Vitreous Associates Medical Group
Dec 21, 2021

Acute Pain in Herpes Zoster Trial in Japan (NPC-06, Placebo)

Not yet recruiting
  • Acute Pain in Herpes Zoster
  • Urayasu, Chiba, Japan
  • +19 more
Jul 29, 2022

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 23, 2022

PD-1 Inhibitor, G-CSF Trial in Guangzhou (Camrelizumab, G-CSF)

Recruiting
  • PD-1 Inhibitor
  • G-CSF
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Nasopharyngeal Carcinoma Trial in Hong Kong (Trans-oral magnifying endoscopy with NBI)

Recruiting
  • Nasopharyngeal Carcinoma
  • Trans-oral magnifying endoscopy with NBI
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Aug 15, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023

IMRT vs 2DRT for NPC Patients

Completed
  • NPC
  • IMRT
  • 2DRT
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Oct 21, 2021

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Cancer
  • Toripalimab
  • Induction chemotherapy and concurrent chemoradiation
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Nov 25, 2022

Multimodal Brain Function Biomarker With NPC

Completed
  • Brain Injuries
  • +4 more
  • BrainScope Ahead 300iP-O
  • +2 more
  • Fayetteville, Arkansas
  • +5 more
Jun 8, 2022